相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Sorafenib or placebo in patients with newly diagnosed acute myeloid leukaemia: long-term follow-up of the randomized controlled SORAML trial
Christoph Roellig et al.
LEUKEMIA (2021)
Machine Learning Integrates Genomic Signatures for Subclassification Beyond Primary and Secondary Acute Myeloid Leukemia
Hassan Awada et al.
BLOOD (2021)
CEBPA Mutations in 4708 Patients with Acute Myeloid Leukemia - Differential Impact of bZIP and TAD Mutations on Outcome
Franziska Taube et al.
BLOOD (2021)
Core outcome set measurement for future clinical trials in acute myeloid leukemia: the HARMONY study protocol using a multi-stakeholder consensus-based Delphi process and a final consensus meeting
Katharina M. Lang et al.
TRIALS (2020)
Application of machine learning in the management of acute myeloid leukemia: current practice and future prospects
Jan-Niklas Eckardt et al.
BLOOD ADVANCES (2020)
Profiling of aberrant DNA methylation in acute myeloid leukemia reveals subclasses of CG-rich regions with epigenetic or genetic association
Claudia Gebhard et al.
LEUKEMIA (2019)
The prognostic impact of tet oncogene family member 2 mutations in patients with acute myeloid leukemia: a systematic-review and meta-analysis
Ruiqi Wang et al.
BMC CANCER (2019)
Intermediate-dose cytarabine plus mitoxantrone versus standard-dose cytarabine plus daunorubicin for acute myeloid leukemia in elderly patients
C. Roellig et al.
ANNALS OF ONCOLOGY (2018)
Machine Learning Detects Pan-cancer Ras Pathway Activation in The Cancer Genome Atlas
Gregory P. Way et al.
CELL REPORTS (2018)
Sequential high-dose cytarabine and mitoxantrone (S-HAM) versus standard double induction in acute myeloid leukemia-a phase 3 study
Jan Braess et al.
LEUKEMIA (2018)
Advances in targeted therapy for acute myeloid leukaemia
Sabine Kayser et al.
BRITISH JOURNAL OF HAEMATOLOGY (2018)
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
Hartmut Doehner et al.
BLOOD (2017)
CEBPA-double-mutated acute myeloid leukemia displays a unique phenotypic profile: a reliable screening method and insight into biological features
Francesco Mannelli et al.
HAEMATOLOGICA (2017)
CEBPA-double-mutated acute myeloid leukemia displays a unique phenotypic profile: a reliable screening method and insight into biological features
Francesco Mannelli et al.
HAEMATOLOGICA (2017)
Genomics of Acute Myeloid Leukemia Diagnosis and Pathways
Lars Bullinger et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Precision oncology for acute myeloid leukemia using a knowledge bank approach
Moritz Gerstung et al.
NATURE GENETICS (2017)
TET2 in Normal and Malignant Hematopoiesis
Robert L. Bowman et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2017)
The role of targeted therapy in the management of patients with AML
Alexander E. Perl
BLOOD ADVANCES (2017)
The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia
Daniel A. Arber et al.
BLOOD (2016)
TP53 mutation in patients with high-risk acute myeloid leukaemia treated with allogeneic haematopoietic stem cell transplantation
Jan M. Middeke et al.
BRITISH JOURNAL OF HAEMATOLOGY (2016)
Increasing intensity of therapies assigned at diagnosis does not improve survival of adults with acute myeloid leukemia
U. Krug et al.
LEUKEMIA (2016)
RUNX1 mutations in acute myeloid leukemia are associated with distinct clinico-pathologic and genetic features
V. I. Gaidzik et al.
LEUKEMIA (2016)
Predicting the Future - Big Data, Machine Learning, and Clinical Medicine
Ziad Obermeyer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Genomic Classification and Prognosis in Acute Myeloid Leukemia
Elli Papaemmanuil et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Favorable prognosis of biallelic CEBPA gene mutations in acute myeloid leukemia patients: a meta-analysis
Hong-Ying Li et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2015)
Addition of sorafenib versus placebo to standard therapy in patients aged 60 years or younger with newly diagnosed acute myeloid leukaemia (SORAML): a multicentre, phase 2, randomised controlled trial
Christoph Rollig et al.
LANCET ONCOLOGY (2015)
Machine learning applications in genetics and genomics
Maxwell W. Libbrecht et al.
NATURE REVIEWS GENETICS (2015)
GATA2 mutations in patients with acute myeloid leukemia-paired samples analyses show that the mutation is unstable during disease evolution
Hsin-An Hou et al.
ANNALS OF HEMATOLOGY (2015)
DNMT3A in haematological malignancies
Liubin Yang et al.
NATURE REVIEWS CANCER (2015)
Application of machine learning algorithms for clinical predictive modeling: a data-mining approach in SCT
R. Shouval et al.
BONE MARROW TRANSPLANTATION (2014)
Big data analytics in healthcare: promise and potential
Wullianallur Raghupathi et al.
HEALTH INFORMATION SCIENCE AND SYSTEMS (2014)
High-Dose Cytarabine Consolidation With or Without Additional Amsacrine and Mitoxantrone in Acute Myeloid Leukemia: Results of the Prospective Randomized AML2003 Trial
Markus Schaich et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
GATA2 mutations are frequent in intermediate-risk karyotype AML with biallelic CEBPA mutations and are associated with favorable prognosis
A. Fasan et al.
LEUKEMIA (2013)
Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia
Timothy J. Ley et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Acquired mutations in ASXL1 in acute myeloid leukemia: prevalence and prognostic value
Marta Pratcorona et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2012)
Topography, Clinical, and Genomic Correlates of 5q Myeloid Malignancies Revisited
Andres Jerez et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Landscape of TET2 mutations in acute myeloid leukemia
S. Weissmann et al.
LEUKEMIA (2012)
Prognostic Relevance of Integrated Genetic Profiling in Acute Myeloid Leukemia
Jay P. Patel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
A novel prognostic model in elderly patients with acute myeloid leukemia: results of 909 patients entered into the prospective AML96 trial
Christoph Roellig et al.
BLOOD (2010)
DNMT3A Mutations in Acute Myeloid Leukemia.
Timothy J. Ley et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
TP53 gene mutation is frequent in patients with acute myeloid leukemia and complex karyotype, and is associated with very poor prognosis
D. Bowen et al.
LEUKEMIA (2009)
Mutations of the TP53 gene in acute myeloid leukemia are strongly associated with a complex aberrant karyotype
C. Haferlach et al.
LEUKEMIA (2008)
The impact of FLT3 internal tandem duplication mutant level, number, size, and interaction with NPM1 mutations in a large cohort of young adult patients with acute myeloid leukemia
Rosemary E. Gale et al.
BLOOD (2008)
Gene-expression profiling identifies distinct subclasses of core binding factor acute myeloid leukemia
Lars Bullinger et al.
BLOOD (2007)
Prevalence and prognostic impact of NPM1 mutations in 1485 adult patients with acute myeloid leukemia (AML)
Christian Thiede et al.
BLOOD (2006)
Use of gene-expression profiling to identify prognostic subclasses in adult acute myeloid leukemia
L Bullinger et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Analysis of FLT3-activating mutations in 979 patients with acute myelogenous leukemia:: association with FAB subtypes and identification of subgroups with poor prognosis
C Thiede et al.
BLOOD (2002)
Statistical modeling: The two cultures
L Breiman
STATISTICAL SCIENCE (2001)
分享论文
